What to know about the temporary Medicare GLP-1 Bridge program
Summary
Starting in July, some people who receive Medicare will be able to get certain GLP-1 medications by paying a single flat monthly fee. This temporary program will last about 18 months, ending at the close of 2027, but many details about how it will work are still not clear.Key Facts
- The program begins in July and will run until the end of 2027.
- It targets Medicare beneficiaries, meaning people who use the U.S. government health insurance for seniors and some disabled individuals.
- Participants will pay one flat fee each month to access GLP-1 medications.
- GLP-1 medications are drugs often used to treat conditions like type 2 diabetes or weight issues.
- The program is temporary, lasting about a year and a half.
- The Centers for Medicare and Medicaid Services (CMS) is managing the program.
- Questions remain about specific details and how the program will function in practice.
- This program aims to make these medications more affordable and easier to access for Medicare users.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.